Abvance Therapeutics
PrivateLast Round
Seed
Jun 24, 2025
Total Funding Raised
$3.9M
Company Overview
Abvance Therapeutics is a biotechnology company developing glucagon-based therapies designed to prevent hypoglycemia and improve glucose management for diabetes patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abvance Therapeutics Comparables
Compare Abvance Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zucara Therapeutics Inc. | 78% | |
| Sensulin | 78% | |
| Zealand Pharma | 71% | |
Abvance Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2025 | ||||
| Debt | Sep 10, 2024 |
Abvance Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helmsley Charitable Trust | Debt |
| Zubi Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2025
Seed round led by Zubi Capital.
Abvance Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abvance Therapeutics's valuation, stock price, and market status.